Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigration
about
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmAndrographolide protects against LPS-induced acute lung injury by inactivation of NF-κBTargeted delivery of therapeutics to endothelium.Targeted modulation of reactive oxygen species in the vascular endotheliumThe 150-kilodalton oxygen-regulated protein ameliorates lipopolysaccharide-induced acute lung injury in miceSystems approaches to design of targeted therapeutic delivery.Factors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium.Endothelial targeting of antibody-decorated polymeric filomicelles.Antioxidant strategies in respiratory medicine.RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applicationsPathogenesis of the systemic inflammatory syndrome and acute lung injury: role of iron mobilization and decompartmentalization.Dynamic factors controlling targeting nanocarriers to vascular endothelium.Endothelial nanomedicine for the treatment of pulmonary disease.Hypoxia selectively activates the CREB family of transcription factors in the in vivo lung.Targeted endothelial nanomedicine for common acute pathological conditions.The Future of Nanoparticle-Directed Venous Therapy.Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactorNeutrophil alpha-defensins cause lung injury by disrupting the capillary-epithelial barrier.Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics?Nanocarrier Hydrodynamics and Binding in Targeted Drug Delivery: Challenges in Numerical Modeling and Experimental Validation.Mitochondrial cytochrome c release is a key event in hyperoxia-induced lung injury: protection by cyclosporin A.Targeting therapeutics to endothelium: are we there yet?The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series).Platelet-Specific Chemokines Contribute to the Pathogenesis of Acute Lung Injury.Limited generation of activated protein C during infusion of the protein C activator thrombin analog W215A/E217A in primates.
P2860
Q27026630-F1EDE232-DA4B-4F83-8A6C-022FA82C27A6Q28486454-9ADAA5A6-1CA0-475C-AD5D-296CDCF4ACF4Q30475849-4140B9CB-582B-4AE2-9302-A81B6B32F5D1Q35098774-43835E0C-C8A4-470A-B841-8162EF1708D4Q35103279-B65704AD-F483-4999-ADAF-F08743275F2BQ35623160-BF4898F6-C92A-4C5F-BB8A-33BA5224DCB3Q35759213-F353C1BE-E654-4962-A00C-5844B1E963AEQ35930068-72E01490-69DA-4D0A-B87E-9AA95C7C5467Q36366782-E981E122-9ADA-4365-92F2-01DE3469A065Q36449335-392B8358-89F2-4AA0-AF91-856E00915EBEQ37022879-A06225D0-D875-4D4C-BDA1-3E318579BB74Q37980236-DD750BA1-3B58-4E93-8D4E-4360C9D8332EQ38267984-48D638C6-96E7-4E74-82E2-BC99435980A2Q38288424-582B339D-A4A6-4CDE-8DD8-17301DA69E0CQ38598987-B5F53D5B-8B5F-4693-8D38-1DD43E0E425FQ38749932-E9B82F3E-E35E-44F3-959E-9199C38C05D4Q39061982-A3D32FEA-4687-44FB-BE9B-E32FF211F719Q40287076-A86CCE27-1AF8-4CBB-A421-2A923E1ECAE6Q42855410-0BFAE794-5E0E-4BE0-9525-D23AE67E051FQ43096315-FDE1E8EF-4F88-4EBC-AFC4-46C59D90C553Q44607635-0D5FB55B-754D-43EC-A5FC-E9C7AD103BE0Q47250590-7015A0B8-419D-45C5-949E-7871848476FBQ47675852-33FF7095-1219-4344-9BCE-F5427348FAB0Q50257338-5A3E1108-968D-4547-A2F6-C7A7CF1CA900Q51286024-EA9382F1-77E4-41CA-B6D0-49836C9E285A
P2860
Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigration
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Vascular immunotargeting of gl ...... and neutrophil transmigration
@ast
Vascular immunotargeting of gl ...... and neutrophil transmigration
@en
type
label
Vascular immunotargeting of gl ...... and neutrophil transmigration
@ast
Vascular immunotargeting of gl ...... and neutrophil transmigration
@en
prefLabel
Vascular immunotargeting of gl ...... and neutrophil transmigration
@ast
Vascular immunotargeting of gl ...... and neutrophil transmigration
@en
P2093
P2860
P1476
Vascular immunotargeting of gl ...... and neutrophil transmigration
@en
P2093
Arnaud Scherpereel
Charalambos C Solomides
Giuseppe G Pietra
Harry Ischiropoulos
Juan-Carlos Murciano
Melpo Christofidou-Solomidou
Rainer Wiewrodt
Sayed A Shah
Stephen Kennel
Steven M Albelda
P2860
P304
P356
10.1016/S0002-9440(10)64935-8
P407
P577
2002-03-01T00:00:00Z